Is Nuvalent, Inc. (NUVL) a Buy, Sell, or Hold?
NASDAQ : NUVL
Nuvalent, Inc. — Stock Grades
$123.96 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 2.33M
- Market Capitalization
- $9.13B
- P/E Ratio
- -20.46
- Dividend Yield
- 0.00%
- Price Target
- $124.00
- Year High
- $123.99
- Year Low
- $71.13
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $16.14
NUVL Stock Grades
| Date | Grading Company | Previous Grade | New Grade | Action |
|---|---|---|---|---|
| 2026-06-24 | Bernstein | Outperform | Market Perform | Downgrade |
| 2026-06-10 | TD Cowen | Buy | Hold | Downgrade |
| 2026-06-10 | Wedbush | Outperform | Neutral | Downgrade |
| 2026-06-10 | UBS | Buy | Neutral | Downgrade |
| 2026-06-10 | Truist Securities | Buy | Hold | Downgrade |
| 2026-06-10 | Barclays | Overweight | Equal Weight | Downgrade |
| 2026-06-10 | Guggenheim | Buy | Neutral | Downgrade |
| 2026-06-09 | HC Wainwright & Co. | Buy | Neutral | Downgrade |
| 2026-06-09 | LifeSci Capital | Outperform | Market Perform | Downgrade |
| 2026-06-09 | Wedbush | Outperform | Neutral | Downgrade |
| 2026-06-09 | Cantor Fitzgerald | Overweight | Neutral | Downgrade |
| 2026-06-09 | Wells Fargo | Overweight | Equal Weight | Downgrade |
| 2026-05-28 | Wedbush | Outperform | Outperform | Maintain |
| 2026-04-21 | HC Wainwright & Co. | Buy | Buy | Maintain |
| 2026-04-08 | Wedbush | Outperform | Outperform | Maintain |
| 2026-02-27 | Cantor Fitzgerald | Overweight | Overweight | Maintain |